Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy.
Clin Case Rep
; 9(11): e05057, 2021 Nov.
Article
en En
| MEDLINE
| ID: mdl-34786197
ABSTRACT
Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half-lives, the typical duration used to guide pre-operative medication recommendations.
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Guideline
Idioma:
En
Revista:
Clin Case Rep
Año:
2021
Tipo del documento:
Article